Archbold Memorial Hospital’s Lewis Hall Singletary Oncology Center was recently granted reaccreditation by the Commission on Cancer (CoC) for three years.
Established in 1922 by the American College of Surgeons, the CoC is a group of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of comprehensive, quality care.
In order to earn accreditation, the cancer center must meet 34 CoC quality care standards and maintain levels of excellence in the delivery of comprehensive patient-centered care. The Singletary Oncology Center has been accredited by the CoC since 1991.
“Being reaccredited by the Commission on Cancer is an accomplishment that benefits both Archbold and our patients,” said Rebecca Troyer, PhD., administrator at Lewis Hall Singletary Oncology Center. “As a CoC-accredited cancer center, our clinicians take a multidisciplinary approach to treating cancer which results in improved patient care.”
The CoC Accreditation Program provides the framework for Archbold to continue enhancing quality of patient care through various cancer-related programs focusing on the full spectrum of cancer care.
Patients at the Singletary Oncology Center have access to state-of-the-art clinical trials and cancer treatments, counseling, a patient navigation program and a survivorship care plan that documents the care each patient receives to improve cancer survivors’ quality of life.
“Our goal is to provide our patients with high quality care,” said Troyer. “This accreditation shows that our Center is focused on providing every patient with the best care possible.”